You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

Family planningHealthReproductive health research

47 Results Found

  • Published research

    Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

  • Published research

    Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial

  • Project

    Innovate FP: Expanding Options, Enhancing Method Choice

    Innovate FP is a contraceptive research project to expand desirable, affordable, quality contraceptive options to better meet the needs of women.
  • Project

    Research for Scalable Solutions (R4S)

    The Research for Scalable Solutions (R4S) project, conducts implementation science research to improve the efficiency, cost-effectiveness and equity of family planning programs in Africa and Asia.
  • News

    Award will continue work to advance contraceptive technology innovation

    The Bill & Melinda Gates Foundation granted a four-year award to expand and strengthen ongoing development and evaluation of new contraceptives, under the Contraceptive Technology Innovation (CTI) Initiative.
  • Published research

    Menstrual bleeding changes are NORMAL: Proposed counseling tool to address common reasons for non-use and discontinuation of contraception

    The authors reviewed commonly used family planning counseling, training and reference materials and found that menstrual bleeding changes were insufficiently addressed. The authors suggest using a new counseling mnemonic tool, “NORMAL,” that provides messages about changes associated with the use of hormonal contraception and the copper IUD.
  • Published research

    Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: A randomised controlled trial

    The authors found that women who self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC) led to a more than 50 percent increase in pregnancy protection through 12 months compared with provider-administered injection. The findings demonstrate that self-injection can address the stubborn problem of early contraceptive discontinuation and that community health workers can safely train women to self-inject. Malawi plans to introduce DMPA-SC self-injection based on these positive findings.
  • Tools

    Quality and Performance Guidance on Selection of Pregnancy Tests for Procurement

    This document provides guidance on quality standards and performance specifications to help inform pregnancy test product selection by international and national procurement groups.
  • Published research

    Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: A systematic review

    Progestin-only contraceptive implants and injectables protect against ectopic pregnancy by being highly effective in preventing pregnancy overall. However, in the case of method failure, levonorgestrel (LNG)-containing contraceptive implants may be more likely to result in ectopic pregnancies than other methods, such as combined hormonal and barrier contraceptives. Women using LNG-containing implants, such as Jadelle or Sino-implant (II), and their providers should be aware of potential signs of ectopic pregnancy on the small chance the method should fail.
  • Feature

    Research explores strategies to integrate family planning with food security and nutrition programming

    Frequent pregnancies and short birth-to-pregnancy intervals can result in poor nutrition for both mother and child.